Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 129

Similar articles for PubMed (Select 23836971)

1.

Preparation, characterization, and in vivo evaluation of tanshinone IIA solid dispersions with silica nanoparticles.

Jiang YR, Zhang ZH, Liu QY, Hu SY, Chen XY, Jia XB.

Int J Nanomedicine. 2013;8:2285-93. doi: 10.2147/IJN.S40374. Epub 2013 Jun 25.

2.

Enhanced dissolution and oral bioavailability of tanshinone IIA base by solid dispersion system with low-molecular-weight chitosan.

Liu QY, Zhang ZH, Jin X, Jiang YR, Jia XB.

J Pharm Pharmacol. 2013 Jun;65(6):839-46. doi: 10.1111/jphp.12047. Epub 2013 Apr 9.

PMID:
23647677
3.

An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188.

Yan HM, Zhang ZH, Jiang YR, Ding DM, Sun E, Jia XB.

Pharmacogn Mag. 2014 Apr;10(Suppl 2):S311-7. doi: 10.4103/0973-1296.133286.

4.

Enhanced dissolution and stability of Tanshinone IIA base by solid dispersion system with nano-hydroxyapatite.

Jiang YR, Zhang ZH, Huang SY, Lu Y, Ma TT, Jia XB.

Pharmacogn Mag. 2014 Jul;10(39):332-7. doi: 10.4103/0973-1296.137375.

5.

Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.

Zhao X, Liu X, Gan L, Zhou C, Mo J.

Arch Pharm Res. 2011 Jun;34(6):949-59. doi: 10.1007/s12272-011-0612-3. Epub 2011 Jul 2.

PMID:
21725816
6.

[Comparison of different preparation methods of tanshinoneporous silica solid dispersion].

Jiang YR, Zhang ZH, Ding DM, Chen XY, Su E, Jia XB.

Zhongguo Zhong Yao Za Zhi. 2013 Oct;38(19):3271-6. Chinese.

PMID:
24422390
7.

Dry hybrid lipid-silica microcapsules engineered from submicron lipid droplets and nanoparticles as a novel delivery system for poorly soluble drugs.

Simovic S, Heard P, Hui H, Song Y, Peddie F, Davey AK, Lewis A, Rades T, Prestidge CA.

Mol Pharm. 2009 May-Jun;6(3):861-72. doi: 10.1021/mp900063t.

PMID:
19358600
8.

Fabrication and evaluation of pH-modulated solid dispersion for telmisartan by spray-drying technique.

Marasini N, Tran TH, Poudel BK, Cho HJ, Choi YK, Chi SC, Choi HG, Yong CS, Kim JO.

Int J Pharm. 2013 Jan 30;441(1-2):424-32. doi: 10.1016/j.ijpharm.2012.11.012. Epub 2012 Nov 19.

PMID:
23174408
10.

Novel Tanshinone II A ternary solid dispersion pellets prepared by a single-step technique: in vitro and in vivo evaluation.

Li J, Liu P, Liu JP, Zhang WL, Yang JK, Fan YQ.

Eur J Pharm Biopharm. 2012 Feb;80(2):426-32. doi: 10.1016/j.ejpb.2011.11.003. Epub 2011 Nov 18.

PMID:
22119664
11.

Enhanced bioavailability of sirolimus via preparation of solid dispersion nanoparticles using a supercritical antisolvent process.

Kim MS, Kim JS, Park HJ, Cho WK, Cha KH, Hwang SJ.

Int J Nanomedicine. 2011;6:2997-3009. doi: 10.2147/IJN.S26546. Epub 2011 Nov 24.

12.

Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance.

Van Eerdenbrugh B, Van Speybroeck M, Mols R, Houthoofd K, Martens JA, Froyen L, Van Humbeeck J, Augustijns P, Van den Mooter G.

Eur J Pharm Sci. 2009 Oct 8;38(3):270-8. doi: 10.1016/j.ejps.2009.08.002. Epub 2009 Aug 15.

PMID:
19686846
13.

Enhancement of solubility and dissolution rate of cryptotanshinone, tanshinone I and tanshinone IIA extracted from Salvia miltiorrhiza.

Yu H, Subedi RK, Nepal PR, Kim YG, Choi HK.

Arch Pharm Res. 2012 Aug;35(8):1457-64. doi: 10.1007/s12272-012-0816-1. Epub 2012 Sep 1.

PMID:
22941489
14.

Preparation and evaluation of raloxifene-loaded solid dispersion nanoparticle by spray-drying technique without an organic solvent.

Tran TH, Poudel BK, Marasini N, Chi SC, Choi HG, Yong CS, Kim JO.

Int J Pharm. 2013 Feb 25;443(1-2):50-7. doi: 10.1016/j.ijpharm.2013.01.013. Epub 2013 Jan 11.

PMID:
23318367
15.

[Study on solid dispersion of binary vector of tanshinone II A].

Jiang Y, Zhang Z, Lu Y, Tang J, Ma T, Jia X.

Zhongguo Zhong Yao Za Zhi. 2012 May;37(10):1383-7. Chinese.

PMID:
22860446
16.

[Study on solid dispersion of copovidone-based tanshinone II(A)].

Jiang YR, Zhang ZH, Xia HJ, Jia XB.

Zhongguo Zhong Yao Za Zhi. 2013 Jan;38(2):174-8. Chinese.

PMID:
23672037
17.

Development of novel itraconazole-loaded solid dispersion without crystalline change with improved bioavailability.

Park YJ, Xuan JJ, Oh DH, Balakrishnan P, Yang HJ, Yeo WH, Lee MK, Choi HG, Yong CS.

Arch Pharm Res. 2010 Aug;33(8):1217-25. doi: 10.1007/s12272-010-0812-2. Epub 2010 Aug 28.

PMID:
20803125
18.

Silymarin-loaded solid nanoparticles provide excellent hepatic protection: physicochemical characterization and in vivo evaluation.

Yang KY, Hwang du H, Yousaf AM, Kim DW, Shin YJ, Bae ON, Kim YI, Kim JO, Yong CS, Choi HG.

Int J Nanomedicine. 2013;8:3333-43. doi: 10.2147/IJN.S50683. Epub 2013 Aug 28.

19.

Physicochemical and pharmacokinetic characterization of amorphous solid dispersion of tranilast with enhanced solubility in gastric fluid and improved oral bioavailability.

Onoue S, Kojo Y, Aoki Y, Kawabata Y, Yamauchi Y, Yamada S.

Drug Metab Pharmacokinet. 2012;27(4):379-87. Epub 2012 Jan 13.

20.

Cefuroxime axetil solid dispersion with polyglycolized glycerides for improved stability and bioavailability.

Dhumal RS, Biradar SV, Aher S, Paradkar AR.

J Pharm Pharmacol. 2009 Jun;61(6):743-51. doi: 10.1211/jpp.61.06.0006.

PMID:
19505364
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk